Showing results (141-150 of 435) with videos related to

Sort By:
Pageof 44
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcomeK T Godder, L J Hazlett, S H Abhyankar, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|July 5, 2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferCatherine M Bollard, Stephen Gottschalk, Ann M Leen, et al.
Cytotherapy|June 8, 2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceAdrian P Gee, Sara Richman, April Durett, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Blood|October 27, 2005
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationRaphaël F Rousseau, Ettore Biagi, Aurélie Dutour, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Blood|August 25, 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationAnn M Leen, Anne Christin, Gary D Myers, et al.
Pageof 44